Product Details
Banzel
Rufinamide100 mg
Tablet
DIN/PIN/NPN
02369613
Manufacturer
Eisai Limited
Formulary Listing Date
2023-04-28
Unit Price
0.8730
Amount MOH Pays
0.8730
Coverage Status
Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
N03AF03
Interchangeable Products
NOLU Clinical Criteria
NOEAP Criteria
Therapeutic Class | Reimbursement Criteria |
---|---|
Anticonvulsants | Rufinamide
For the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients who meet the following criteria:
1If an adequate trial of lamotrigine and/or topiramate is not possible due to intolerance or contraindication, a less costly AED that is listed as a benefit on the Ontario drug benefit formulary must be tried in its place Dose: Maximum daily dose is 1,300 mg per day for patients less than 30 kg; and 3,200 mg per day for patients 30 kg or greater Exclusion Criteria: Funding will not be approved for the following circumstances:
|